Promoter DNA methylation has been shown to affect transcriptional repression and participates in tumor oncogenesis.[38] Therefore, the promoter methylation levels of SCD or FADS2 were compared, and UALCAN analysis was performed using TCGA-BRCA samples. This evidence concerns the gene FADS2 and neoplasm.